US equities
|
ANT
$97.17
▲+17.07%
NVDA
$145.98
▼-3.30%
AMD
$489.19
▼-7.72%
MU
$690.44
▼-2.10%
SPCX
$138.43
▼-3.53%
MSFT
$498.30
▼-1.97%
AAPL
$349.21
▼-0.92%
AMZN
$257.37
▼-3.87%
ANT
$97.17
▲+17.07%
NVDA
$145.98
▼-3.30%
AMD
$489.19
▼-7.72%
MU
$690.44
▼-2.10%
SPCX
$138.43
▼-3.53%
MSFT
$498.30
▼-1.97%
AAPL
$349.21
▼-0.92%
AMZN
$257.37
▼-3.87%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Jim Fickenscher
Recent news which mentions Jim Fickenscher
Zynerba Pharmaceuticals Enters Into Equity Purchase Agreement For Up To $20M
July 21, 2022
Tickers
ZYNE
Tags
ZYNE
Markets
Jim Fickenscher
From
Benzinga